Fourmula One Plus (F1 Plus) For Health
Fourmula One Plus (F1 Plus) For Health
Fourmula One Plus (F1 Plus) For Health
PGS/DOH SCORECARD
ATTACHED
LGU HOSPITAL INTERNATIONAL
OPCR AGENCY PARTNER
SCORECARD SCORECARD SCORECARD
Central Regional DOH SCORECARD
TRCs
Office Office Hospitals
3 Health
5 15
Specific
Pillars
Goals Objectives
55
Health Sector Indicators
10 Impact
Indicators 45 Outcome/Output
Indicators
10 Impact Indicators
G1. Better Health Outcomes
Indicator 1: Average life expectancy
Indicator 2: Maternal Mortality Ratio per 100,000 live births
Indicator 3: Infant Mortality rate per 1,000 live births
Indicator 4: Mortality from cardiovascular disease, cancer, diabetes or chronic respiratory disease
Indicator 5: Tuberculosis incidence per 100,000 population
Indicator 6: Prevalence of stunting among under-five children
SO1. Efficiently mobilize and equitably distribute more resources for health
Indicator 11: Domestic general government health expenditure as % of GDP
Indicator 12: Domestic general government health expenditure per capita (disaggregated by wealth quintile)
Indicator 13: Social Health Insurance as % of THE (disaggregated by wealth quintile)
Indicator 14: Government financing as % of THE (disaggregated by national/local, by wealth quintile)
SO4. Increase access to quality essential health PROPOSED DOH SCORECARD INDICATORS
products and services Central Office CHDs
Family Health Commodity Provision* Commodity Provision*
% CHDs where all of the target % of target provinces/HUCs/ICCs
population are provided with where all of the target population
Indicator 19: Modern Contraceptive Prevalence Rate public health commodities are provided with public health
Indicator 20: Adolescent birth rate commodities, (disaggregated by
commodity type)
Indicator 21: % of Fully Immunized Child
Indicator 22: Incidence of low birth weight infants
SO4. Increase access to quality essential health PROPOSED DOH SCORECARD INDICATORS
products and services (cont.) Central Office CHDs
Communicable and Diseases for Elimination TA Provision** TA Provision**
No. of public health programs and % of target provinces/HUCs/ICCs/
local health systems with developed municipalities provided with
Indicator 27: Tuberculosis treatment coverage capacity building packages and have capacity building package on public
been cascaded to CHDs health programs and local health
Indicator 28: % of ART coverage systems including SDN based on LIPH
Indicator 29: % of provinces that are Malaria free
Policies
Indicator 30: % of provinces that are Filariasis free Policies % of policies cascaded to all
% of medium-term policy agenda provinces/HUCs/ICCs/ Municipalities
Environmental Health items with issued policies
Indicator 42: % of applications for permits, licenses or • % of applications for permits/clearances, licenses or
accreditation processed within the accreditation processed within the citizen charter timeline
citizen charter timeline (disaggregated (disaggregated by CHD, FDA, HFSRB, BOQ)
by LTO for facilities and CPR for
products) • % of backlog applications for permits/clearances, licenses or
accreditation processed within prescribed timeline
Indicator 43: % of newly registered pharmaceutical
(disaggregated by CHD, FDA, HFSRB, BOQ)
products with post marketing
• % of newly registered pharmaceutical products
surveillance with post-marketing surveillance
Indicator 44: % of provinces and points of entry/exit
with Epidemiology and Surveillance • % of international ports and airports with
functional Epidemiology and Surveillance Unit
Unit that can detect and respond to
Public Health Emergencies of
International and National Concern
REGULATION PILLAR
Ensure high quality and affordable health products, devices, facilities and services.
Indicator 50: % of health facilities with no stock out of • % of public health facilities with no stock-outs of
essential drugs and vaccines (disaggregated by centrally procured commodities (FP commodities,
type of facilities to classify essential drugs per Basic EPI, TB commodities, ART for detected cases,
level) Malaria and Filaria drugs for endemic provinces),
(disaggregated by type of facility and index products)
SO13: Ensure generation of evidence in health
policy development • % of new drugs funded by DOH that have
undergone HTA review
A management tool
• Translate several plans into a singular vision through a Strategy Map
• Agency scorecard assesses the translation of the organizational strategy
into concrete and quantifiable outcomes
A participatory process
• Strategic partnership between the organization and the sectors it
closely interacts with, as well as transparent executive leadership
PGS PRINCIPLES
Development of the scorecards are guided by the following principles:
1 STRATEGIC
International
Health Technical assistance provision
Health Scorecards
Key Stakeholders Responsible Units
• DOH as an institution; based on mandate and corporate plan.
DOH SPMS as the cascading framework.
• Lead office in DOH: HPDPB
• LGUs
LGU • Lead office in DOH: BLHSD
International
• International Partners in the health sector
Health • Lead office in DOH: BIHC
Health Scorecards
19
Indicators
37 24
55
Indicators Indicators
Indicators
19
Indicators
6
Indicators
NOW WE’RE ALL SET